Pacira BioSciences, Inc. financial data

Symbol
PCRX on Nasdaq
Location
Brisbane, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 26 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 306% % -6%
Quick Ratio 69% % 27%
Debt-to-equity 91% % -0.08%
Return On Equity 0.95% %
Return On Assets 0.49% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 40,489,894 shares -13%
Common Stock, Shares, Outstanding 41,116,739 shares -11%
Entity Public Float $757,500,000 USD -19%
Common Stock, Value, Issued $48,000 USD 2.1%
Weighted Average Number of Shares Outstanding, Basic 44,566,000 shares -3.6%
Weighted Average Number of Shares Outstanding, Diluted 45,042,000 shares -2.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $726,411,000 USD 3.6%
Cost of Revenue $149,749,000 USD -12%
Research and Development Expense $117,312,000 USD 44%
Costs and Expenses $707,220,000 USD -8.7%
Operating Income (Loss) $19,191,000 USD -91%
Nonoperating Income (Expense) $2,317,000 USD -123%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $16,874,000 USD -98%
Income Tax Expense (Benefit) $9,840,000 USD -73%
Net Income (Loss) Attributable to Parent $7,034,000 USD -90%
Earnings Per Share, Basic 0.16 USD/shares -86%
Earnings Per Share, Diluted 0.16 USD/shares -87%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $158,545,000 USD -43%
Accounts Receivable, after Allowance for Credit Loss, Current $124,069,000 USD 9.5%
Inventory, Net $152,863,000 USD 22%
Assets, Current $547,974,000 USD -26%
Deferred Income Tax Assets, Net $123,854,000 USD -5%
Property, Plant and Equipment, Net $140,690,000 USD -16%
Operating Lease, Right-of-Use Asset $41,777,000 USD -15%
Intangible Assets, Net (Excluding Goodwill) $368,100,000 USD -14%
Goodwill $20,214,000 USD
Assets $1,264,917,000 USD -19%
Accounts Payable, Current $15,150,000 USD -21%
Employee-related Liabilities, Current $37,841,000 USD 31%
Accrued Liabilities, Current $95,601,000 USD 19%
Liabilities, Current $120,590,000 USD -61%
Deferred Income Tax Liabilities, Net $4,213,000 USD
Operating Lease, Liability, Noncurrent $36,176,000 USD -19%
Other Liabilities, Noncurrent $20,572,000 USD 22%
Liabilities $571,806,000 USD -26%
Accumulated Other Comprehensive Income (Loss), Net of Tax $4,327,000 USD 1162%
Retained Earnings (Accumulated Deficit) $199,322,000 USD 3.4%
Stockholders' Equity Attributable to Parent $693,111,000 USD -11%
Liabilities and Equity $1,264,917,000 USD -19%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $35,459,000 USD -28%
Net Cash Provided by (Used in) Financing Activities $2,994,000 USD -6.3%
Net Cash Provided by (Used in) Investing Activities $25,629,000 USD -65%
Common Stock, Shares Authorized 250,000,000 shares 0%
Common Stock, Shares, Issued 47,890,777 shares 1.7%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $6,836,000 USD -78%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $158,545,000 USD -43%
Interest Paid, Excluding Capitalized Interest, Operating Activities $2,715,000 USD -32%
Deferred Tax Assets, Valuation Allowance $26,130,000 USD 5.3%
Deferred Tax Assets, Gross $186,708,000 USD -1.5%
Operating Lease, Liability $46,015,000 USD -14%
Depreciation $33,700,000 USD 57%
Payments to Acquire Property, Plant, and Equipment $8,548,000 USD 201%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $11,018,000 USD -88%
Lessee, Operating Lease, Liability, to be Paid $53,541,000 USD -16%
Property, Plant and Equipment, Gross $278,393,000 USD -7.2%
Operating Lease, Liability, Current $9,839,000 USD 11%
Lessee, Operating Lease, Liability, to be Paid, Year Two $12,303,000 USD -0.13%
Lessee, Operating Lease, Liability, to be Paid, Year One $12,755,000 USD 3.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.069 pure 0.14%
Deferred Income Tax Expense (Benefit) $1,397,000 USD -60%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $7,526,000 USD -28%
Lessee, Operating Lease, Liability, to be Paid, Year Three $11,155,000 USD -7.6%
Deferred Tax Assets, Operating Loss Carryforwards $120,280,000 USD -3.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $10,728,000 USD 14%
Lessee, Operating Lease, Liability, to be Paid, Year Four $11,042,000 USD 1.1%
Operating Lease, Payments $3,262,000 USD 1.3%
Additional Paid in Capital $1,064,623,000 USD 5.5%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $57,288,000 USD 0%
Depreciation, Depletion and Amortization $21,168,000 USD 15%
Deferred Tax Assets, Net of Valuation Allowance $119,641,000 USD -8.2%
Share-based Payment Arrangement, Expense $57,502,000 USD 12%
Interest Expense $14,033,000 USD -64%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%